Fisetin inhibits laryngeal carcinoma through regulation of AKT/NF-κB/mTOR and ERK1/2 signaling pathways

Biomedicine and Pharmacotherapy

Volumn 83, Issue , 2016, Pages 1164-1174

  Zhang, Xi Jun ^a   Jia, Shen Shan ^a  

^a HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

AKT NF B mTOR; ERK1 2; Fisetin; Laryngeal cancer; Proliferation

Indexed keywords

CASPASE 3; FISETIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MAMMALIAN TARGET OF RAPAMYCIN; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PROTEIN KINASE B; FLAVONOID; LIGHT CHAIN 3, HUMAN; MICROTUBULE ASSOCIATED PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; TARGET OF RAPAMYCIN KINASE;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; AUTOPHAGY; CANCER INHIBITION; CELL CYCLE REGULATION; CELL PROLIFERATION; CELL PROLIFERATION ASSAY; CELL STRUCTURE; CELL VIABILITY; COLONY FORMATION; CONTROLLED STUDY; ENZYME INACTIVATION; FLOW CYTOMETRY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IN VIVO STUDY; LARYNX CARCINOMA; MALE; MOUSE; MTT ASSAY; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; TUMOR CELL; TUMOR GROWTH; TUMOR INVASION; TUMOR MODEL; TUMOR VOLUME; TUMOR XENOGRAFT; WESTERN BLOTTING; WOUND HEALING; ANIMAL; BAGG ALBINO MOUSE; CELL SHAPE; CELL SURVIVAL; CHEMISTRY; DRUG EFFECTS; DRUG SCREENING; LARYNGEAL NEOPLASMS; METABOLISM; NUDE MOUSE; PATHOLOGY; TUMOR CELL LINE; UPREGULATION;

ANIMALS; APOPTOSIS; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SHAPE; CELL SURVIVAL; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FLAVONOIDS; HUMANS; LARYNGEAL NEOPLASMS; MALE; MICE, INBRED BALB C; MICE, NUDE; MICROTUBULE-ASSOCIATED PROTEINS; NF-KAPPA B; PROTO-ONCOGENE PROTEINS C-AKT; SIGNAL TRANSDUCTION; TOR SERINE-THREONINE KINASES; UP-REGULATION; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84989249048     PISSN: 07533322     EISSN: 19506007     Source Type: Journal    
DOI: 10.1016/j.biopha.2016.08.035     Document Type: Article

References (61)

1. [1] Siegel, R.L., Miller, K.D., Jemal, A., Cancer statistics 2015. CA Cancer J. Clin. 65 (2015), 5–29.
2. [2] Boring, C.C., Squires, T.S., Health, C.W., Cancer statistics for African Americans. CA Cancer J. Clin. 42 (2015), 7–17.
3. [3] Hermans, R., Staging of laryngeal and hypopharyngeal cancer: value of imaging studies. Eur. Radiol. 16 (2006), 2386–2400.
4. [4] Hoffman, H.T., Porter, K., Karnell, L.H., Cooper, J.S., Weber, R.S., Langer, C.J., et al. Laryngeal cancer in the United States: changes in demographics, patterns of care, and survival. Laryngoscope 116 (2006), 1–13.
5. [5] Pignon, J.P., le Maître, A., Maillard, E., Bourhis, J., Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): an update on 93 randomised trials and 17,346 patients. Radiother. Oncol. 92 (2009), 4–14.
6. [6] Vokes, E.E., Competing roads to larynx preservation. J. Clin. Oncol. 31 (2013), 833–836.
7. [7] Strojan, P., Haigentz, M., Bradford, C.R., Wolf, G.T., Hartl, D.M., Langendijk, J.A., et al. Chemoradiotherapy vs. total laryngectomy for primary treatment of advanced laryngeal squamous cell carcinoma. Oral. Oncol. 49 (2013), 283–286.
8. [8] Stanković, M., Milisavljević, D., Stojanov, D., Zivić, M., Zivaljević, S., Stanković, I., et al. Influential factors, complications and survival rate of primary and salvage total laryngectomy for advanced laryngeal cancer. Coll. Antropol. 36 (2012), 7–12.
9. [9] Raj, L., Ide, T., Gurkar, A.U., Foley, M., Schenone, M., Li, X., et al. Selective killing of cancer cells by a small molecule targeting the stress response to ROS. Nature 475 (2011), 231–234.
10. [10] Lee, Y.R., Wu, W.C., Ji, W.T., Chen, J.Y., Cheng, Y.P., Chiang, M.K., et al. Reversine suppresses oral squamous cell carcinoma via cell cycle arrest and concomitantly apoptosis and autophagy. J. Biomed. Sci., 19, 2012, 9.
11. [11] Tang, F.Y., The silver bullet for cancer prevention: chemopreventive effects of carotenoids. Biomedicine 2 (2012), 117–121.
12. [12] Adhami, V.M., Syed, D.N., Khan, N., Mukhtar, H., Dietary flavonoid fisetin: a novel dual inhibitor of PI3K/Akt and mTOR for prostate cancer management. Biochem. Pharmacol. 84 (2012), 1277–1281.
13. [13] Ishige, K., Schubert, D., Sagara, Y., Flavonoids protect neuronal cells from oxidative stress by three distinct mechanisms. Free Radic. Biol. Med. 30 (2001), 433–446.
14. [14] Zbarsky, V., Datla, K.P., Parkar, S., Rai, D.K., Aruoma, O.I., Dexter, D.T., Neuroprotective properties of the natural phenolic antioxidants curcumin and naringenin but not quercetin and fisetin in a 6-OHDA model of Parkinson's disease. Free Radic. Res. 39 (2005), 1119–1125.
15. [15] Smith, M.L., Murphy, K., Doucette, C.D., Greenshields, A.L., Hoskin, D.W., The dietary flavonoid fisetin causes cell cycle arrest caspase-dependent apoptosis, and enhanced cytotoxicity of chemotherapeutic drugs in triple-negative breast cancer cells. J. Cell Biochem. 117 (2016), 1913–1925.
16. [16] Lin, M.T., Lin, C.L., Lin, T.Y., Cheng, C.W., Yang, S.F., et al. Synergistic effect of fisetin combined with sorafenib in human cervical cancer HeLa cells through activation of death receptor-5 mediated caspase-8/caspase-3 and the mitochondria-dependent apoptotic pathway. Tumour Biol. 37 (2016), 6987–6996.
17. [17] Choi, H.S., Kim, M.K., Choi, Y.K., Shin, Y.C., Cho, S.G., Ko, S.G., Rhus verniciflua Stokes (RVS) and butein induce apoptosis of paclitaxel-resistant SKOV-3/PAX ovarian cancer cells through inhibition of AKT phosphorylation. BMC Complement. Altern. Med., 16, 2016, 122.
18. [18] Klimaszewska-Wisniewska, A., Halas-Wisniewska, M., Tadrowski, T., Gagat, M., Grzanka, D., Grzanka, A., Paclitaxel and the dietary flavonoid fisetin: a synergistic combination that induces mitotic catastrophe and autophagic cell death in A549 non-small cell lung cancer cells. Cancer Cell Int., 16, 2016, 10.
19. [19] Pal, H.C., Baxter, R.D., Hunt, K.M., Agarwal, J., Elmets, C.A., Athar, M., et al. Fisetin a phytochemical, potentiates sorafenib-induced apoptosis and abrogates tumor growth in athymicnude mice implanted with BRAF-mutated melanoma cells. Oncotarget 6 (2015), 28296–282311.
20. [20] Pal, H.C., Diamond, A.C., Strickland, L.R., Kappes, J.C., Katiyar, S.K., Elmets, C.A., et al. Fisetin a dietary flavonoid, augments the anti-invasive and anti-metastatic potential of sorafenib in melanoma. Oncotarget 7 (2016), 1227–1241.
21. [21] Lindsay, J., Esposti, M.D., Gilmore, A.P., Bcl-2 proteins and mitochondria—specificity in membrane targeting for death. Biochim. Biophys. Acta 1813 (2011), 532–539.
22. [22] Panda, P.K., Mukhopadhyay, S., Das, D.N., Sinha, N., Naik, P.P., Bhutia, S.K., Mechanism of autophagic regulation in carcinogenesis and cancer therapeutics. Semin. Cell Dev. Biol. 39 (2015), 43–55.
23. [23] Puissant, A., Fenouille, N., Auberger, P., When autophagy meets cancer through p62/SQSTM1. Am. J. Cancer Res. 2 (2012), 397–413.
24. [24] Chambard, J.C., Lefloch, R., Pouyssegur, J., Lenormand, P., ERK implication in cell cycle regulation. Biochim. Biophys. Acta 1773 (2007), 1299–1310.
25. [25] Huang, L., Chen, T., Chen, C., Chen, S., Liu, Y., Wu, J., Shao, Z., Prognostic and predictive value of Phospho-p44/42 and pAKT in HER2-positive locally advanced breast cancer patients treated with anthracycline-based neoadjuvant chemotherapy. World J. Surg. Oncol., 11, 2013, 307.
26. [26] Kavitha, K., Kowshik, J., Kishore, T.K., Baba, A.B., Nagini, S., Astaxanthin inhibits NF-κB and Wnt/β-catenin signaling pathways via inactivation of Erk/MAPK and PI3 K/Akt to induce intrinsic apoptosis in a hamster model of oral cancer. Biochim. Biophys. Acta. Gen. Subj. 1830 (2013), 4433–4444.
27. [27] Chaudhary, P.M., Eby, M.T., Jasmin, A., Kumar, A., Liu, L., Hood, L., Activation of the NF-kappaB pathway by caspase 8 and its homologs. Oncogene 19 (2000), 4451–4460.
28. [28] Zhao, Y., Lei, M., Wang, Z., Qiao, G., Yang, T., Zhang, J., TCR-induced, PKC-θ-mediated NF-κB activation is regulated by a caspase-8-caspase-9-caspase-3 cascade. Biochem. Biophys. Res. Commun. 450 (2014), 526–531.
29. [29] Xu, B., Gogol, M., Gaudenz, K., Gerton, J.L., Improved transcription and translation with l-leucine stimulation of mTORC1 in Roberts syndrome. BMC Genom., 17, 2016, 25.
30. [30] Cuny, F., Meunier, A., Heutte, N., Rame, J.P., de Raucourt, D., Babin, E., et al. Laryngeal preservation in ENT oncology. Retrospective series of 246 patients managed in the Caen University Hospital and Francois Baclesse Cancer Care Center between 1998 and 2008. Eur. Ann. Otorhinolaryngol. Head Neck Dis. 132 (2015), 129–134.
31. [31] Jenckel, F., Knecht, R., State of the art in the treatment of laryngeal cancer. Anticancer Res. 33 (2013), 4701–4710.
32. [32] Kim, J.A., Lee, S., Kim, D.E., Kim, M., Kwon, B.M., Han, D.C., Fisetin, a dietary flavonoid, induces apoptosis of cancer cells by inhibiting HSF1 activity through blocking its binding to the hsp70 promoter. Carcinogenesis 36 (2015), 696–706.
33. [33] Chen, Y., Wu, Q., Song, L., He, T., Li, Y., Li, L., et al. Polymeric micelles encapsulating fisetin improve the therapeutic effect in colon cancer. ACS Appl. Mater Interfaces 7 (2015), 534–542.
34. [34] Hill, C.U., Saad, S.E., Britton, R.G., Gescher, A.J., Sale, S., Brown, K., et al. Inhibition of prostate cancer cell growth by 3′,4′,5′-trimethoxyflavonol (TMFol). Cancer Chemother. Pharmacol. 76 (2015), 179–185.
35. [35] Arif, H., Rehmani, N., Farhan, M., Ahmad, A., Hadi, S.M., Mobilization of copper ions by flavonoids in human peripheral lymphocytes leads to oxidative DNA breakage: a structure activity study. Int. J. Mol. Sci., 16, 2015 26754-2669.
36. [36] Gao, Z., Gammoh, N., Wong, P.M., Erdjument-Bromage, H., Tempst, P., Jiang, X., Processing of autophagic protein LC3 by the 20S proteasome. Autophagy 6 (2010), 126–137.
37. [37] Nagendraprabhu, P., Sudhandiran, G., Astaxanthin inhibits tumor invasion by decreasing extracellular matrix production and induces apoptosis in experimental rat colon carcinogenesis by modulating the expressions of ERK-2, NFkB and COX-2. Invest. New Drugs 29 (2011), 207–224.
38. [38] Tentner, A.R., Lee, M.J., Ostheimer, G.J., Samson, L.D., Lauffenburger, D.A., Yaffe, M.B., Combined experimental and computational analysis of DNA damage signaling reveals context-dependent roles for Erk in apoptosis and G1/S arrest after genotoxic stress. Mol. Syst. Biol., 8, 2012, 568.
39. [39] Taherian, A., Mazoochi, T., Different expression of extracellular signal-Regulated kinases (ERK) 1/2 and phospho-Erk proteins in MBA-MB-231 and MCF-7 cells after chemotherapy with doxorubicin or docetaxel. Iran. J. Basic Med. Sci. 15 (2012), 669–677.
40. [40] Tekedereli, I., Alpay, S.N., Tavares, C.D., Cobanoglu, Z.E., Kaoud, T.S., Sahin, I., et al. Targeted silencing of elongation factor 2 kinase suppresses growth and sensitizes tumors to doxorubicin in an orthotopic model of breast cancer. PLoS One, 7, 2012, e41171.
41. [41] Abrams, S.L., Steelman, L.S., Shelton, J.G., Wong, E.W., Chappell, W.H., Bäsecke, J., et al. The Raf/MEK/ERK pathway can govern drug resistance, apoptosis and sensitivity to targeted therapy. Cell Cycle 9 (2010), 1781–1791.
42. [42] Monje, P., Hernandez-Losa, J., Lyons, R.J., Castellone, M.D., Gutkind, J.S., Regulation of the transcriptional activity of c-Fos by ERK. A novel role for the prolyl isomerase PIN1. J. Biol. Chem. 280 (2005), 35081–35084.
43. [43] Yothaisong, S., Thanee, M., Namwat, N., Yongvanit, P., Boonmars, T., Puapairoj, A., et al. Opisthorchis viverrini infection activates the PI3K/AKT/PTEN and wnt/beta-catenin signaling pathways in a cholangiocarcinogenesis model. Asian Pac. J. Cancer Prev. 15 (2014), 10463–10468.
44. [44] Cheng, P., Dai, W., Wang, F., Lu, J., Shen, M., Chen, K., et al. Ethyl pyruvate inhibits proliferation and induces apoptosis of hepatocellular carcinoma via regulation of the HMGB1-RAGE and AKT pathways. Biochem. Biophys. Res. Commun. 443 (2014), 1162–1168.
45. [45] Haupt, S., Berger, M., Goldberg, Z., Haupt, Y., Apoptosis—the p 53 network. J. Cell Sci. 116 (2003), 4077–4085.
46. [46] Wendel, H.G., de Stanchina, J.S., Fridman, A., Malina, S., Kogan, S., et al. Survival signalling by akt and eif4e in oncogenesis and cancer therapy. Nature 428 (2004), 332–337.
47. [47] Brunelle, J.K., Letai, A., Control of mitochondrial apoptosis by the Bcl-2 family. J. Cell Sci. 122 (2009), 437–441.
48. [48] Lee, S., Braun, C.R., Bird, G.H., Walensky, L.D., Photoreactive stapled peptides to identify and characterize BCL-2 family interaction sites by mass spectrometry. Methods Enzymol. 544 (2014), 25–48.
49. [49] Lindsay, J., Esposti, M.D., Gilmore, A.P., Bcl-2 proteins and mitochondria—specificity in membrane targeting for death. Biochim. Biophys. Acta 1813 (2011), 532–539.
50. [50] Anitha, P., Priyadarsini, R.V., Kavitha, K., Thiyagarajan, P., Nagini, S., Ellagic acid coordinately attenuates Wnt/beta-catenin and NF-kappaB signaling pathways to induce intrinsic apoptosis in an animal model of oral oncogenesis. Eur. J. Nutr. 52 (2013), 75–84.
51. [51] Farhana, L., Dawson, M.I., Fontana, J.A., Apoptosis induction by a novel retinoid-related molecule requires nuclear factor-kappaB activation. Cancer Res. 65 (2005), 4909–4917.
52. [52] Chaturvedi, M.M., Sung, B., Yadav, V.R., Kannappan, R., Aggarwal, B.B., NF-kappaB addiction and its role in cancer: one size does not fit allˮ. Oncogene 30 (2011), 1615–1630.
53. [53] Wang, Q., Liu, S., Tang, Y., Liu, Q., Yao, Y., MPT64 protein from Mycobacterium tuberculosis inhibits apoptosis of macrophages through NF-kB-miRNA21-Bcl-2 pathway. PLoS One, 9, 2014, e100949.
54. [54] Silke, J., Vucic, D., IAP family of cell death and signaling regulators. Methods Enzymol. 545 (2014), 35–65.
55. [55] Hui, K.K., Kanungo, A.K., Elia, A.J., Henderson, J.T., Caspase-3 deficiency reveals a physiologic role for Smac/DIABLO in regulating programmed cell death. Cell Death Differ. 18 (2011), 1780–1790.
56. [56] Vince, J.E., Wong, W.W., Khan, N., Feltham, R., Chau, D., Ahmed, A.U., et al. Iap antagonists target ciap1 to induce TNFα-dependent apoptosis. Cell 131 (2007), 682–693.
57. [57] Stehlik, C., de Martin, R., Kumabashiri, I., Schmid, J.A., Binder, B.R., Lipp, J., Nuclear factor (NF)-κB-regulated X-chromosome-linked iap gene expression protects endothelial cells from tumor necrosis factor α-induced apoptosis. J. Exp. Med. 188 (1998), 211–216.
58. [58] Chung, J., Bachelder, R.E., Lipscomb, E.A., Shaw, L.M., Mercurio, A.M., Integrin (alpha 6 beta 4) regulation of eif-4e activity and vegf translation: a survival mechanism for carcinoma cells. J. Cell. Biol. 158 (2002), 165–174.
59. [59] Wu, Y.T., Tan, H.L., Huang, Q., Ong, C.N., Shen, H.M., Activation of the pi3k-akt-mtor signaling pathway promotes necrotic cell death via suppression of autophagy. Autophagy 5 (2009), 824–834.
60. [60] Hu, P., Han, Z., Couvillon, A.D., Exton, J.H., Critical role of endogenous akt/iaps and mek1/erk pathways in counteracting endoplasmic reticulum stress-induced cell death. J. Biol. Chem. 279 (2004), 49420–49429.
61. [61] Kato, H., Nakajima, S., Saito, Y., Takahashi, S., Katoh, R., Kitamura, M., Mtorc1 serves er stress-triggered apoptosis via selective activation of the ire1-jnk pathway. Cell Death Differ. 19 (2012), 310–320.